In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

In this article, we are going to look at where Moderna, Inc. (NASDAQ ... and a supportive regulatory environment, Goldman Sachs referred to it as an “undervalued opportunity.” ...

US indices retreat on tariff worries as VIX jumps to 22.44. Nvidia drops 3.9%, Microsoft falls 2.2%, while defensive sectors provide limited market support.

The Goldman Sachs Equal Weight U.S. Large Cap Equity ... Looking at individual holdings, Moderna Inc (MRNA) accounts for about 0.22% of total assets, followed by Entegris Inc (ENTG) and Dollar ...

U.S. equities jumped at midday on signs the tariffs planned for April 2 by President Donald Trump won't affect as many industries as had been thought.

Goldman Sachs cashed in on stock market turmoil over President Donald Trump’s tariffs — with the bank’s stock traders bagging ...

"It's early to call heads or tails or direction of travel on how this will play out," CEO David Solomon said of Washington's ...

Goldman Sachs beat first-quarter profit estimates as its traders capitalized on volatile markets to bring in record equities ...

Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy ...

(Reuters) - Goldman Sachs raised its end-2025 gold (GC=F) price forecast to $3,700 per ounce from $3,300, with a projected range of $3,650-$3,950, citing stronger-than-expected demand from central ...